Jury Stuns Merck With $8M Verdict For Fosamax Plaintiff
In the first-ever win on jawbone-death claims related to Merck & Co.'s osteoporosis drug Fosamax, jurors awarded $8 million in compensatory damages Friday to bellwether plaintiff Shirley Boles....To view the full article, register now.
Already a subscriber? Click here to view full article